Total Payments
$237,797
2024 Payments
$13,371
Companies
82
Transactions
1,618
Medicare Patients
32,799
Medicare Billing
$2.4M
Payment Breakdown by Category
Other$163,115 (68.6%)
Food & Beverage$32,418 (13.6%)
Consulting$22,695 (9.5%)
Travel$19,298 (8.1%)
Education$271.11 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $163,115 | 107 | 68.6% |
| Food and Beverage | $32,418 | 1,353 | 13.6% |
| Consulting Fee | $22,695 | 14 | 9.5% |
| Travel and Lodging | $19,298 | 128 | 8.1% |
| Education | $271.11 | 16 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $81,523 | 222 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $74,061 | 187 | $0 (2024) |
| Allergan, Inc. | $15,395 | 54 | $0 (2021) |
| Lilly USA, LLC | $11,327 | 94 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,206 | 83 | $0 (2024) |
| GENZYME CORPORATION | $7,671 | 10 | $0 (2024) |
| Avadel Specialty Pharmaceuticals, LLC | $6,073 | 12 | $0 (2018) |
| IDORSIA PHARMACEUTICALS US INC | $5,625 | 20 | $0 (2024) |
| ARALEZ PHARMACEUTICALS US INC. | $5,021 | 23 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $4,366 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,371 | 173 | GENZYME CORPORATION ($7,671) |
| 2023 | $7,658 | 122 | Novo Nordisk Inc ($4,424) |
| 2022 | $22,200 | 171 | Novo Nordisk Inc ($13,226) |
| 2021 | $19,788 | 159 | Novo Nordisk Inc ($12,921) |
| 2020 | $18,010 | 191 | Novo Nordisk Inc ($6,938) |
| 2019 | $50,352 | 254 | Janssen Pharmaceuticals, Inc ($19,161) |
| 2018 | $45,539 | 241 | Janssen Pharmaceuticals, Inc ($15,234) |
| 2017 | $60,879 | 307 | Janssen Pharmaceuticals, Inc ($29,924) |
All Payment Transactions
1,618 individual payment records from CMS Open Payments — Page 1 of 65
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: PAIN | ||||||
| 12/17/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,002.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $111.98 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | Cash or cash equivalent | $33.50 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $59.79 | General |
| Category: Hematology | ||||||
| 11/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Endocrinology | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: PAIN | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $108.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: Cardio-renal | ||||||
| 11/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 6,371 | 11,130 | $1.1M | $361,044 |
| 2022 | 44 | 8,728 | 13,677 | $1.3M | $442,734 |
| 2021 | 44 | 9,963 | 15,827 | $1.5M | $855,997 |
| 2020 | 43 | 7,737 | 14,163 | $1.6M | $789,491 |
Total Patients
32,799
Total Services
54,797
Medicare Billing
$2.4M
Procedure Codes
166
All Medicare Procedures & Services
166 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 810 | 1,987 | $335,803 | $92,196 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 693 | 1,881 | $216,315 | $80,807 | 37.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 822 | 822 | $147,960 | $37,709 | 25.5% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 167 | 202 | $56,560 | $28,117 | 49.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 359 | 359 | $30,156 | $25,679 | 85.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 508 | 514 | $20,046 | $15,652 | 78.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 97 | 99 | $25,245 | $11,392 | 45.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 434 | 1,176 | $23,520 | $11,151 | 47.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 126 | 163 | $41,402 | $9,389 | 22.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 71 | 148 | $13,912 | $6,876 | 49.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 773 | 776 | $102,432 | $6,750 | 6.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 42 | 42 | $10,794 | $6,645 | 61.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 147 | 479 | $19,160 | $4,627 | 24.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 29 | 29 | $5,278 | $3,793 | 71.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 194 | 194 | $5,626 | $3,545 | 63.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 162 | 162 | $5,508 | $3,526 | 64.0% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 50 | 80 | $3,200 | $2,026 | 63.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 138 | 158 | $5,530 | $1,561 | 28.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 25 | 27 | $5,076 | $1,468 | 28.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 34 | 37 | $2,738 | $1,215 | 44.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 51 | 51 | $1,428 | $936.87 | 65.6% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 22 | 22 | $1,100 | $898.92 | 81.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $1,131 | $888.27 | 78.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 21 | 21 | $5,565 | $769.34 | 13.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 126 | 202 | $1,212 | $685.41 | 56.6% |
About Dr. Beshara Helou, MD
Dr. Beshara Helou, MD is a Internal Medicine healthcare provider based in Georgetown, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407811490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beshara Helou, MD has received a total of $237,797 in payments from pharmaceutical and medical device companies, with $13,371 received in 2024. These payments were reported across 1,618 transactions from 82 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($163,115).
As a Medicare-enrolled provider, Helou has provided services to 32,799 Medicare beneficiaries, totaling 54,797 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 166 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Georgetown, DE
- Active Since 04/20/2006
- Last Updated 03/06/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1407811490
Products in Payments
- XARELTO (Drug) $44,566
- INVOKANA (Drug) $29,354
- Rybelsus (Drug) $15,765
- Tresiba (Drug) $13,036
- RYBELSUS (Drug) $12,443
- Ozempic (Drug) $11,653
- Victoza (Drug) $9,915
- JARDIANCE (Drug) $9,695
- VRAYLAR (Drug) $8,802
- KEVZARA (Biological) $7,671
- UBRELVY (Drug) $7,116
- Noctiva (Drug) $6,073
- QUVIVIQ (Drug) $5,625
- YOSPRALA (Drug) $4,774
- Xultophy 100/3.6 (Drug) $4,045
- UTIBRON (Drug) $2,911
- TZIELD (Biological) $2,147
- SOLIQUA (Drug) $2,047
- Saxenda (Drug) $785.56
- Vascepa (Drug) $730.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Georgetown
Dr. Fabricio Alarcon, M.d, M.D
Internal Medicine — Payments: $63,477
Internal Medicine $63,477
Mr. Michael Nacol, Md, MD
Internal Medicine — Payments: $13,410
Internal Medicine $13,410
Robert Martin, M.d, M.D
Internal Medicine — Payments: $11,407
Internal Medicine $11,407
Dr. Arturo Dominguez, M.d, M.D
Internal Medicine — Payments: $9,599
Internal Medicine $9,599
Dr. Matthew Birdwhistell, D.o, D.O
Internal Medicine — Payments: $9,532
Internal Medicine $9,532
Benjamin Lyon, M.d, M.D
Internal Medicine — Payments: $7,969
Internal Medicine $7,969